Virus Entry Inhibitors | Stopping the Enemy at the Gate. Questo articolo non è disponibile.
Lingua: inglese
Editore: Springer, 2022
- Rilegato
- Nuovo

Condizione: Nuovo
EUR 159,40
Descrizione dell’articolo da parte del venditore
Virus Entry Inhibitors | Stopping the Enemy at the Gate | Shibo Jiang (u. a.) | Buch | Advances in Experimental Medicine and Biology | x | Englisch | 2022 | Springer | EAN 9789811687013 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Codice articolo 120795682
- Titolo
- Virus Entry Inhibitors | Stopping the Enemy at the Gate
- Autore
- Shibo Jiang (u. a.)
- Editore
- Springer
- Anno di pubblicazione
- 2022
- Condizione
- Neu
- Rilegatura
- Buch
- Lingua
- inglese
- ISBN 10
- 9811687013
- ISBN 13
- 9789811687013
- Peso dell'articolo
- 735 grammi
- Dimensioni
- 260 x 183 x 19 mm
- Cataloghi dei venditori
- Bücher
This book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Dr. Shibo Jiang is a professor of School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, China. He has served as an Editorial Consultant for The Lancet, Editorial Board Member for Emerging Microbes and Infection, Antiviral Research, Viruses, Retrovirology, BiochimBiophys Acta, Biomedical Journal, and Microbes and Infection. Dr. Jiang’s research interest is to develop antiviral therapeutics and vaccines against HIV, RSV, HPV, SARS-CoV, MERS-CoV, SARS-CoV-2, EBOV, ZIKV, NiV, LASV and influenza viruses. He has published 523 peer-reviewed papers in international journals, including Cell, Nature, Science, Lancet, etc. with more than 33,500 citations and h-index of 93 (Google Scholar).
Dr. Lu Lu is a professor of School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, China. He serves as the committee member of Zoonoses Etiology Branch of the Chinese Society for Microbiology (CSM) and Associate director of Youth Committee of Medical Microbiology and Immunology branch of CSM. Dr. Lu’s research focuses on development of novel antiviral drugs and vaccines. He has published more than 118 articles in peer-reviewed international journals in this field, including Cell, Science, etc.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.